SCHEMBL29564991

SCHEMBL29564991

CC(C)(C)OC(=O)NCCNc1ccc(Br)cn1.CC(C)(C)OC(=O)OC(=O)OC(C)(C)C

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ BCHE P06276 1/20 0.42
▸ RAB9A P51151 2/20 0.42
▸ NPC1 O15118 1/20 0.42
▸ FPR3 P25089 4/20 0.41
▸ FPR2 P25090 4/20 0.41
▸ SUV39H2 Q9H5I1 2/20 0.41
▸ MALT1 Q9UDY8 1/20 0.41
▸ CPB2 Q96IY4 1/20 0.41
▸ LATS1 O95835 1/20 0.40
▸ STK17B O94768 1/20 0.40
▸ STK17A Q9UEE5 1/20 0.40
▸ PRKAB2 O43741 1/20 0.40
▸ PRKAG1 P54619 1/20 0.40
▸ PRKAA2 P54646 1/20 0.40
▸ PRKAA1 Q13131 1/20 0.40
▸ PRKAG3 Q9UGI9 1/20 0.40
▸ PRKAG2 Q9UGJ0 1/20 0.40
▸ PRKAB1 Q9Y478 1/20 0.40
▸ TSHR P16473 1/20 0.40
▸ ALDH1A1 P00352 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30931818 0.94 BCHE (0.46) BCHERAB9ANPC1FPR3FPR2
SCHEMBL12964548 0.94 BCHE (0.46) BCHERAB9ANPC1FPR3FPR2
SCHEMBL30931847 0.87 STK17B (0.53) RAB9ANPC1FPR3FPR2CPB2
SCHEMBL21564563 0.87 STK17B (0.53) RAB9ANPC1FPR3FPR2CPB2
SCHEMBL18768690 0.80 BCHE (0.47) BCHESUV39H2MALT1LATS1STK17B
SCHEMBL4491782 0.79 BCHE (0.46) BCHESUV39H2MALT1LATS1STK17B
SCHEMBL29711794 0.78 HCAR3 (0.60) BCHEMALT1LATS1STK17BSTK17A
SCHEMBL3553610 0.78 HCAR3 (0.60) BCHEMALT1LATS1STK17BSTK17A
SCHEMBL13390910 0.78 BCHE (0.44) BCHEFPR3FPR2SUV39H2MALT1
SCHEMBL22242641 0.78 PCSK9 (0.54) RAB9ANPC1CPB2TSHRALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3978472-B1 BIARYL MONABACTAM COMPOUNDS AND METHODS OF USE THEREOF FOR THE TREATMENT OF BACTERIAL INFECTIONS MERCK SHARP & DOHME LLC (US) 2024-10-16 — — EP disclosed
EP-3978472-A1 BIARYL MONABACTAM COMPOUNDS AND METHODS OF USE THEREOF FOR THE TREATMENT OF BACTERIAL INFECTIONS MERCK SHARP & DOHME CORP. (US) 2022-04-06 — — EP disclosed
Send feedback